Search research articles
Contact Us
Filters
Showing results (121-130 of 174) with videos related to
Page
of 18
Sort By:
Blood Advances
|
January 4, 2018
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
Sham Mailankody, Dickran Kazandjian, Neha Korde, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Blood
|
November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood Advances
|
April 15, 2024
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
Anna J Howard, Isabel Concepcion, Alice X Wang, et al.
Blood Cancer Journal
|
May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood
|
May 10, 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, et al.
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Eclinicalmedicine
|
March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
Neha Korde, Elizabet Tavitian, Donna Mastey, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 174) with videos related to
Sort By:
Page
of 18
Blood Advances
|
January 4, 2018
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
Sham Mailankody, Dickran Kazandjian, Neha Korde, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Blood
|
November 3, 2022
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, et al.
Blood Advances
|
April 15, 2024
Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies
Anna J Howard, Isabel Concepcion, Alice X Wang, et al.
Blood Cancer Journal
|
May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood
|
May 10, 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
Ross S Firestone, Nicholas D Socci, Tala Shekarkhand, et al.
Blood Cancer Journal
|
November 2, 2025
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
Eric Jurgens, Tala Shekarkhand, Colin Rueda, et al.
Blood Cancer Journal
|
April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma
Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Eclinicalmedicine
|
March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study
Neha Korde, Elizabet Tavitian, Donna Mastey, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Page
of 18